Johnson & Johnson (JNJ)

JNJ · Health Care · United States

Johnson & Johnson (JNJ) is a company in the Health Care sector, based in United States. The stock is held in 23 ETFs we track – with its largest weight of 10.50 % in XUHL (msci-usa-health-care). Anyone holding one of these ETFs also owns a small indirect stake in Johnson & Johnson.

Very high ETF coverage: 23 of the 95 ETFs we cover hold Johnson & Johnson, spread across 12 indices. That puts the stock in more ETFs than 90.2 % of the 4,334 stocks we cover.

Held in23 ETFs

Highest weight10.50 %

Indices12

SectorHealth Care

CountryUnited States

ISINUS4781601046

WKN853260

Data note 1

About Johnson & Johnson

Johnson & Johnson develops and sells prescription medicines and medical technology. The Innovative Medicine segment covers areas such as oncology, immunology and neuroscience; the MedTech segment sells surgical, orthopedic, cardiovascular and vision products. The consumer health business with brands such as Neutrogena and Tylenol was separated in 2023 as Kenvue. Founded in 1886, the company is based in New Brunswick, New Jersey.

Data note 2

Price chart

Data note 3

Performance

Performance
Year to date	+29.2 %	1 year	+51.5 %
1 month	+1.9 %	3 months	+14.1 %
Calendar year 2025	+43.1 %

52W

Data note 4

Measured in euros, Johnson & Johnson returned +31.5 % year to date and +55.0 % over one year. The gap to the dollar figures above comes from the exchange rate alone: each daily price is converted at the ECB euro reference rate for the same day.

Data note 5

Risk metrics

Max drawdown-15.1 %

Volatility p.a.19.1 %

Data note 6

Below peak-4.0 %

Beta to S&P 500-0.19

Correlation to S&P 500-0.13

The close on Sep 16, 2026 was 4.0 % below the highest close since Jul 11, 2024, reached on Sep 3, 2026. Over the last 252 trading days, on days when the S&P 500 rose or fell 1 %, Johnson & Johnson moved on average 0.19 % in the opposite direction. The correlation of -0.13 shows how reliable that average is: the broad market explained only a small share of the daily moves.

Data note 7

Correlated with

The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.

Correlated with
Instrument	r	−1 … +1
AbbVie Inc.	+0.65
Eli Lilly and Company	+0.63
Ventas Inc.	+0.59
Republic Services Inc.	+0.58
Arch Capital Group Ltd.	+0.55
Consolidated Edison Inc.	+0.55
S&P 500 Informationstechnologie	-0.53
Broadcom Inc.	-0.51
nVent Electric plc	-0.49

Data note 8

Key financials

Latest reported fiscal year (FY2025, period end 2025-12-28) as filed with the SEC.

Revenue94.2 bn $

Net income26.8 bn $

Diluted EPS11.03 $

Net margin28.5 %

Gross margin67.9 %

Return on equity32.9 %

Equity ratio40.9 %

Revenue growth+6.0 %

Revenue and profit by fiscal year
Fiscal year	Revenue	Net income	Margin
FY2023	85.2	35.2	41.3 %
FY2024	88.8	14.1	15.8 %
FY2025	94.2	26.8	28.5 %

Data note 9

Held in these ETFs

Held in these ETFs
ETF	Index	Weight	per €1,000 in the ETF
XUHL / XUHC	msci-usa-health-care	10.50 %	€105.00
SPFS	msci-world-health-care	7.74 %	€77.40
XDWH	msci-world-health-care	7.72 %	€77.20
CIND	dow-jones	3.08 %	€30.80
XDEM	msci-world-momentum	2.52 %	€25.20
XDEB	msci-world-minimum-volatility	1.49 %	€14.90
XDEQ	msci-world-quality	1.20 %	€12.00
SPYL / SPY5	sp500	0.99 %	€9.90
SXR8	sp500	0.99 %	€9.90
XD9U / XD9D	msci-usa	0.99 %	€9.90
SWWD	msci-world	0.71 %	€7.10
EUNL	msci-world	0.71 %	€7.10
SPPW	msci-world	0.71 %	€7.10
XDWD / XDWL	msci-world	0.71 %	€7.10
SPYY	msci-acwi	0.63 %	€6.30
IUSQ	msci-acwi	0.63 %	€6.30
WIMI	msci-world-imi	0.62 %	€6.20
SPYI / SPSA	msci-acwi-imi	0.52 %	€5.20

Data note 10

The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to Johnson & Johnson as of the fund's latest holdings list.

Weight in EUNL since 2019

Sep 30, 2019Sep 16, 2026

In EUNL, a fund tracking the MSCI World, Johnson & Johnson had a weight of 0.83 % on Sep 30, 2019 and 0.71 % on Sep 16, 2026. Its share peaked at 0.98 % on Mar 31, 2020. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.

Data note 11

How much Johnson & Johnson overlaps with other holdings in a portfolio is shown by the Portfolio X-Ray and the ETF overlap check.

Stocks with similar ETF exposure

Names that reach a portfolio through largely the same funds as Johnson & Johnson — the figure counts the ETFs holding both.

Data note 12

Key figures side by side

Key figures compared with stocks of similar ETF exposure
Stock	1 year	Volatility p.a.	Net margin	Revenue growth
Johnson & Johnson	+51.5 %	19.1 %	28.5 %	+6.0 %
UnitedHealth Group Incorporated	+10.4 %	41.1 %	2.7 %	+11.8 %
Eli Lilly and Company	+48.8 %	38.3 %	31.7 %	+44.7 %
Quest Diagnostics Incorporated	+37.1 %	23.0 %	9.0 %	+11.8 %
AbbVie	+21.4 %	26.9 %	6.9 %	+8.6 %
Abbott Laboratories	-22.9 %	24.1 %	14.7 %	+5.7 %
Cardinal Health	+56.7 %	26.4 %	0.7 %	-1.9 %
Cencora	+9.8 %	26.4 %	0.5 %	+9.3 %
McKesson Corporation	+28.0 %	28.6 %	1.2 %	+12.4 %

Return and volatility from our daily closing prices in US dollars; margin and growth from the latest SEC annual filing. Fiscal years do not all end on the same date.